Ipamorelin
Popular in wellness clinics for its potential to support lean muscle, better sleep, and recovery. Often paired with CJC-1295. Not FDA-approved — talk to your doctor.
This peptide is not FDA-approved for any indication. Human use outside of clinical trials is not recommended.
The basics
- Generic Name
- ipamorelin
- Brand Names
- None (not an approved product)
- Regulatory Status
- Early Research
- Therapeutic Areas
- Growth Hormone, Endocrine
Important: This peptide is not yet FDA-approved
Ipamorelin has not been approved by the FDA for any use in humans. That means it hasn't gone through the rigorous testing process that confirms a drug is safe and effective. Products sold online have not been evaluated by any regulatory body.
What it does
Ipamorelin (ipamorelin) is a synthetic peptide that researchers are studying, but it's not yet FDA-approved for any human use. Selective growth hormone secretagogue that stimulates the pituitary gland to release growth hormone without significantly affecting cortisol or prolactin levels.
The research is still early. Most studies so far are in animals or lab settings, so we don't know for sure how well this translates to real-world results in people.
How it's taken
Subcutaneous injection (typically before bed)
How people access it
Category 1 compounding-eligible since February 2026. Requires a prescription sent to a licensed compounding pharmacy. Often prescribed alongside CJC-1295. Typical cost: $200-400/month.
Regulatory Status
Not FDA-approved. Commonly used in wellness clinics as a growth hormone secretagogue.
Any use in humans outside of an FDA-authorized clinical trial would require an Investigational New Drug (IND) application. Products marketed as “for research use only” are not legally intended for human administration.
What the Evidence Shows
The evidence base for Ipamorelin consists primarily of preclinical studies (animal models and in vitro experiments). There are no completed, large-scale, peer-reviewed clinical trials establishing safety or efficacy in humans. The gap between promising animal data and proven human benefit is substantial — many compounds that show effects in animal studies fail to demonstrate safety or efficacy in human trials.
Marketing claims made by online sellers and “peptide clinics” frequently overstate the evidence and omit critical information about risks and unknowns.
Other options to consider
Depending on what you're hoping to achieve, there may be FDA-approved treatments that have been rigorously tested and proven to work. Discuss evidence-based options with your own healthcare provider to find what fits your specific goals.
Browse our full peptide directory to see FDA-approved options that might work for you.
Common Questions
No. Ipamorelin is not FDA-approved for any use. It's commonly used in wellness clinics but hasn't gone through the rigorous FDA approval process.
They're often used together because they work on complementary pathways — CJC-1295 stimulates growth hormone release while ipamorelin amplifies the signal. But neither is FDA-approved.
Some people report improved sleep quality, which may be related to growth hormone's role in deep sleep. But clinical evidence specifically for sleep is limited.
Curious about what IS approved?
Check out FDA-approved peptides that address similar goals — with established safety profiles and real clinical evidence.
See Approved Options